Please login to the form below

Not currently logged in
Email:
Password:

Creston buys PAN

Healthcare ad agency, PAN Advertising, has been acquired by marketing services group, Creston

Creston, the marketing services group, has bought independent healthcare advertising agency, PAN Advertising, in a deal with a potential total value of £18.8m.

Under the deal, Creston will pay an initial consideration of £10.1m plus up to £300,000 dependent on the net assets of PAN. An additional deferred consideration of up to a maximum of £8.4m is dependent upon the financial performance of the agency in the period to March 31, 2009.

PAN has grown significantly since it was established in 1992, to become one of the leading full-service agencies in healthcare, boasting a client list that includes Boehringer Ingelheim (BI), Bristol-Myers Squibb (BMS), Cephalon, GlaxoSmithKline, Organon, Schering and Wyeth.

Growth at the agency has been fuelled by several major UK product launches, such as Singulair, Crestor, Spiriva and Abilify, alongside expansion into international markets and pan-European launches for BI, BMS and Ipsen.

PAN managing director, Ben Davies, and director of brand planning, Craig Mills, will remain at the company, while chief executive, Tony Yates, will leave immediately to concentrate on his other company Solaris Health.

Creston, now seen as one of the fastest growing publicly-listed marketing services companies, has struck 10 takeover deals since it was formed in 2001, including the acquisition of PR firm, Red Door Communications, in 2005.

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics